Suppr超能文献

干细胞疗法与固有淋巴细胞

Stem Cell Therapy and Innate Lymphoid Cells.

作者信息

Verma Divya, Verma Mukesh, Mishra Rangnath

机构信息

Division of Allergy & Immunology, Department of Medicine, National Jewish Health, Denver, USA.

Global Institute of Stem Cell Research and Therapy, San Diego, USA.

出版信息

Stem Cells Int. 2022 Aug 2;2022:3530520. doi: 10.1155/2022/3530520. eCollection 2022.

Abstract

Innate lymphoid cells have the capability to communicate with other immune cell types to coordinate the immune system functioning during homeostasis and inflammation. However, these cells behave differently at the functional level, unlike T cells, these cells do not need antigen receptors for activation because they are activated by the interaction of their receptor ligation. In hematopoietic stem cell transplantation (HSCT), T cells and NK cells have been extensively studied but very few studies are available on ILCs. In this review, an attempt has been made to provide current information related to NK and ILCs cell-based stem cell therapies and role of the stem cells in the regulation of ILCs as well. Also, the latest information on the differentiation of NK cells and ILCs from CD34+ hematopoietic stem cells is covered in the article.

摘要

固有淋巴细胞有能力与其他免疫细胞类型进行交流,以在稳态和炎症期间协调免疫系统的功能。然而,这些细胞在功能水平上表现不同,与T细胞不同,这些细胞不需要抗原受体来激活,因为它们通过受体连接的相互作用而被激活。在造血干细胞移植(HSCT)中,T细胞和NK细胞已得到广泛研究,但关于固有淋巴细胞的研究却很少。在本综述中,我们试图提供与基于NK细胞和固有淋巴细胞的干细胞疗法相关的当前信息,以及干细胞在固有淋巴细胞调节中的作用。此外,本文还涵盖了关于从CD34+造血干细胞分化出NK细胞和固有淋巴细胞的最新信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/209f/9363162/edfb9fd8c84b/SCI2022-3530520.001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验